Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

Well that was one of the shortest rallies ever. Disappointing royalties yet again (is Shire selling any HyQ), out of control spending on PEG trials through to 2020 ($450m of which is still unfunded), three major Enhanze partnership failures including the world's biggest selling drug, and unconvincing messy data from the PEG Phase 2 trial culminating with most brokers only giving it a 60% chance of approval in 2020, have more than offset the so called Helen cherry picked headline news. The problem now is that 2017 will be a year of no major news other than SQ Mabthera approval in the US, which everyone says is a gimme. More patience required then - another 4 years worth.